Rigel Pharmaceuticals, Inc. (RIGL) Releases Preliminary Results for Q4 2025
RigelRigel(US:RIGL) Yahoo Finance·2026-01-16 23:26

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is one of the Best Performing Affordable Stocks Under 40.OnJanuary12,RigelPharmaceuticals,Inc.(NASDAQ:RIGL)releaseditspreliminaryresultsforthefourthquarterof2025andalsoprovidedits2026outlook.AlthoughthecompanyissettoreleaseitsofficialresultsonMarch3,thepreliminarydatasuggeststhatthefourthquarterrevenuewillbearound40. On January 12, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) released its preliminary results for the fourth quarter of 2025 and also provided its 2026 outlook. ​Although the company is set to release its official results on March 3, the preliminary data suggests that the fourth quarter revenue will be around 69.8 million, compared to $57.6 million for the same period of 2024. Moreover, management expects fou ...